| 1 | Dimebon | - | - | - | - | [1] 8 8 💬
|
| 2 | Dimebon (latrepirdine) | [1] Latrepirdine Latrepirdine (Dimebon) | [2] Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
(Dimebon) 💬
| [6] ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 💬
|
| 3 | Dimebon + Dextromethorphan | [1] Dextromethorphan Dextromethorphan | [3] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 💬
|
| 4 | Dimebon + Ketoconazole | [1] Ketoconazole Ketoconazole | [1] Ketoconazole
Ketoconazole
💬
| - | - | [1] 8 8 💬
|
| 5 | Dimebon + Omeprazole | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 8 8 💬
|
| 6 | Dimebon alone | - | - | - | - | [1] 8 8 💬
|
| 7 | Dimebon Dihydrochloride | - | - | - | - | [1] 8 8 💬
|
| 8 | Dimebon IR | - | - | - | - | [1] 8 8 💬
|
| 9 | Dimebon IR Tablet | - | - | - | - | [1] 8 8 💬
|
| 10 | Dimebon MR1 | - | - | - | - | [1] 8 8 💬
|
| 11 | Dimebon MR2 | - | - | - | - | [1] 8 8 💬
|
| 12 | Dimebon MR3 | - | - | - | - | [1] 8 8 💬
|
| 13 | Dimebon MR4 | - | - | - | - | [1] 8 8 💬
|
| 14 | Dimebon Transdermal | - | - | - | - | [1] 8 8 💬
|
| 15 | Latrepirdine (Dimebon) | [1] Latrepirdine Latrepirdine (Dimebon) | [2] Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
(Dimebon) 💬
| [6] ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 💬
|